These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22315967)

  • 21. Use of serum concentrations of interleukin-18 and monocyte chemoattractant protein-1 as prognostic indicators in primary immune-mediated hemolytic anemia in dogs.
    Kjelgaard-Hansen M; Goggs R; Wiinberg B; Chan DL
    J Vet Intern Med; 2011; 25(1):76-82. PubMed ID: 21092010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Red blood cell glycophorins as B and T-cell antigens in canine autoimmune haemolytic anaemia.
    Barker RN; Elson CJ
    Vet Immunol Immunopathol; 1995 Aug; 47(3-4):225-38. PubMed ID: 8571543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IgG red blood cell autoantibodies in autoimmune hemolytic anemia bind to epitopes on red blood cell membrane band 3 glycoprotein.
    Victoria EJ; Pierce SW; Branks MJ; Masouredis SP
    J Lab Clin Med; 1990 Jan; 115(1):74-88. PubMed ID: 1688911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isotype-specific antibodies in horses and dogs with immune-mediated hemolytic anemia.
    Wilkerson MJ; Davis E; Shuman W; Harkin K; Cox J; Rush B
    J Vet Intern Med; 2000; 14(2):190-6. PubMed ID: 10772492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell-Free DNA and DNase Activity in Dogs with Immune-Mediated Hemolytic Anemia.
    Jeffery U; Ruterbories L; Hanel R; LeVine DN
    J Vet Intern Med; 2017 Sep; 31(5):1441-1450. PubMed ID: 28833583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systematic review of prognostic factors for mortality in dogs with immune-mediated hemolytic anemia.
    Swann JW; Skelly BJ
    J Vet Intern Med; 2015 Jan; 29(1):7-13. PubMed ID: 25586014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Erythrocyte membrane proteins reactive with human (warm-reacting) anti-red cell autoantibodies.
    Leddy JP; Falany JL; Kissel GE; Passador ST; Rosenfeld SI
    J Clin Invest; 1993 Apr; 91(4):1672-80. PubMed ID: 8473510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous administration of human immune globulin in dogs with immune-mediated hemolytic anemia.
    Scott-Moncrieff JC; Reagan WJ; Snyder PW; Glickman LT
    J Am Vet Med Assoc; 1997 Jun; 210(11):1623-7. PubMed ID: 9170090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Use of human intravenous immunoglobulin in dogs with primary immune mediated hemolytic anemia].
    Gerber B; Steger A; Hässig M; Glaus TM
    Schweiz Arch Tierheilkd; 2002 Apr; 144(4):180-5. PubMed ID: 12038216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of enoxaparin in dogs with primary immune-mediated hemolytic anemia: 21 cases.
    Panek CM; Nakamura RK; Bianco D
    J Vet Emerg Crit Care (San Antonio); 2015; 25(2):273-7. PubMed ID: 25773906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Red cell-reactive non-specific immunoglobulins and autoantibodies in the sera of normal and anaemic dogs.
    Barker RN; Elson CJ
    Vet Immunol Immunopathol; 1993 Dec; 39(4):339-54. PubMed ID: 8116215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The utility of diagnostic tests for immune-mediated hemolytic anemia.
    ; MacNeill AL; Dandrieux J; Lubas G; Seelig D; Szladovits B
    Vet Clin Pathol; 2019 Oct; 48 Suppl 1():7-16. PubMed ID: 31502273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-erythrocyte antibodies and disease associations in anemic and nonanemic dogs.
    Morley P; Mathes M; Guth A; Dow S
    J Vet Intern Med; 2008; 22(4):886-92. PubMed ID: 18498322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dogs cast NETs too: Canine neutrophil extracellular traps in health and immune-mediated hemolytic anemia.
    Jeffery U; Kimura K; Gray R; Lueth P; Bellaire B; LeVine D
    Vet Immunol Immunopathol; 2015 Dec; 168(3-4):262-8. PubMed ID: 26574161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of immune-mediated hemolytic anemia on flow velocities in the portal vein and caudal vena cava measured by use of pulsed-wave Doppler ultrasonography in dogs.
    Smith RP; Koenigshof AM; Smith DJ; Strom PR; Nelson NC
    Am J Vet Res; 2018 May; 79(5):518-524. PubMed ID: 29688778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of hypercoagulability in dogs with primary immune-mediated hemolytic anemia by means of thromboelastography.
    Fenty RK; Delaforcade AM; Shaw SE; O'Toole TE
    J Am Vet Med Assoc; 2011 Feb; 238(4):463-7. PubMed ID: 21320015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunosuppressive therapy for canine immune-mediated hemolytic anemia.
    Al-Ghazlat S
    Compend Contin Educ Vet; 2009 Jan; 31(1):33-41, 44; quiz 44. PubMed ID: 19241356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ACVIM consensus statement on the treatment of immune-mediated hemolytic anemia in dogs.
    Swann JW; Garden OA; Fellman CL; Glanemann B; Goggs R; LeVine DN; Mackin AJ; Whitley NT
    J Vet Intern Med; 2019 May; 33(3):1141-1172. PubMed ID: 30847984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary 11-dehydrothromboxane B
    Conway EA; Evans NP; Ridyard AE
    J Vet Intern Med; 2022 Jan; 36(1):86-96. PubMed ID: 34859495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of immune-mediated hemolytic anemia with individually adjusted heparin dosing in dogs.
    Helmond SE; Polzin DJ; Armstrong PJ; Finke M; Smith SA
    J Vet Intern Med; 2010; 24(3):597-605. PubMed ID: 20384956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.